As Delta problem moved from the shadow up on the stage, becoming one of the most crucial disease in Hepatology area, our STC 2019 is dedicated to hepat itis D, for the first time in the history of APASL STC topics. As hepatitis Delta occurs only with HBV infection, we will discuss hepatitis B, its epidemiology, work - up, current treatment and new horizons in the developing pharmaceutical agents. The scient ific program will include the topics presented by the best speakers and the experts in Delta and B hepatitis.
This conference is a good chance to meet and interact with leading clinical professionals and researches and to obtain latest information for hepa tologists.